Inventor

Yongfeng Wang

Inventor
Tianjin, CN

Overview

19→
Patents
2005–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 19 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07DHeterocyclic compounds20%
A61KPreparations for medical, dental or toiletry purposes12%
A61BDiagnosis10%
C07CAcyclic or carbocyclic compounds10%
B25JManipulators5%
H04LTransmission of digital information, e.g. telegraphic communication5%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry2%
C01BNon-metallic elements2%
C07BGeneral methods of organic chemistry2%
PatentTitleYear
11,097,953Process for producing liquid polysilanes and isomer enriched higher silanes202110,864,626Parallel mechanism with six degrees of freedom having arc-shaped prismatic pairs in three branches202010,710,2493 DOF parallel mechanism with 3 branched-chains202010,368,866Flexible drive member, end-effector, and surgical instrument using the same201910,307,158Articulating assembly and surgical instrument using the same201910,275,742Methods and devices for managing emails201910,253,007Taxanes compounds, preparation method therefor, and uses thereof201910,238,384Suturing nail20199,890,175'Taxane compound, and preparation method and use thereof'20189,884,870'Polymorphic substance of yonkenafil hydrochloride, preparation method therefor, and composition and use thereof'20189,700,307'Suturing nail'20178,821,913'Controlled releases system containing temozolomide'20148,461,165'2-Substituted phenyl-5,7-dihydrocarbyl-3,7-dihydropyrrolo[2,3-d] pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof'20137,899,935'Method and system for data synchronization'20117,745,433'2-Substituted phenyl-5, 7-dihydrocarbyl-3, 7-dihydropyrrolo [2, 3-D] pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof'20107,741,483'Process for making substituted pyrrolo[2,3-d]pyrimidine derivatives as inhibitors of phosphodiesterase 5'20107,579,336'Pharmaceutical composition comprising temozolomide ester'20097,173,021'Synthesis of temozolomide esters as potent anticancer pro-drugs for topical and transdermal applications in treatments of cancers'20076,933,650'Wear indicator'2005

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2009–2019Based in Tianjin, CN· patent location history
2010Patents assigned to TIANJIN NORTH PHARMA SCI TECH (2)· patent assignee history
2011–2020Based in Shenzhen, CN· patent location history
2013–2014Patents assigned to WANG YONGFENG (2)· patent assignee history
2017–2020Patents assigned to SHENZHEN INST OF ADV TECH CAS (4)· patent assignee history
2017–2019Based in Guangdong, CN· patent location history
2018–2019Patents assigned to JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD (2)· patent assignee history
2018Based in Jiangsu, CN· patent location history
2019Patents assigned to REACH SURGICAL INC (2)· patent assignee history
2021Based in Garnet Valley, PA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SHENZHEN INST OF ADV TECH CAS42017–2020
JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD22018–2019
REACH SURGICAL INC22019
TIANJIN NORTH PHARMA SCI TECH22010
WANG YONGFENGself22013–2014
Locations
LocationPatentsSpan
Tianjin, CN92009–2019
Shenzhen, CN42011–2020
Guangdong, CN22017–2019
Garnet Valley, Pennsylvania, US12021
Jiangsu, CN12018